Anthony James Kennedy

Title: The Innovative Contributions of Anthony James Kennedy

Introduction

Anthony James Kennedy is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of boronic acid salts. With a total of 2 patents to his name, Kennedy's work is recognized for its potential applications in parenteral formulations and oral dosage forms.

Latest Patents

Kennedy's latest patents include innovative formulations that utilize boronic acid salts. One of his patents focuses on "Boronic acid salts useful in parenteral formulations," which details salts of a peptide boronic acid drug, such as Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH). The counter-ion to the boronate may be an alkali metal or derived from a strongly basic organic nitrogen-containing compound. Another significant patent is for "Multivalent metal salts of boronic acids," which describes salts of a pharmaceutically acceptable divalent metal and an organoboronic acid drug. Examples of such metals include calcium, magnesium, and zinc, and the organoboronic acid drug may serve as a boropeptide protease inhibitor.

Career Highlights

Kennedy is currently associated with Trigen GmbH, where he continues to innovate and develop new pharmaceutical solutions. His work has garnered attention for its potential to improve drug formulations and enhance therapeutic efficacy.

Collaborations

Some of his notable coworkers include John Joseph Deadman and Mark Dolman, who contribute to the collaborative environment at Trigen GmbH.

Conclusion

Anthony James Kennedy's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on boronic acid salts demonstrates the potential for advancements in drug formulation and delivery systems.